BIO-key Intl BKYI will release its quarterly earnings report on Thursday, 2024-11-14. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate BIO-key Intl to report an earnings per share (EPS) of $-0.58.
The market awaits BIO-key Intl's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Here's a look at BIO-key Intl's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | ||||
| EPS Actual | -1 | -0.32 | -0.25 | -1.44 |
| Price Change % | -10.0% | 9.0% | -7.000000000000001% | -26.0% |
Market Performance of BIO-key Intl's Stock
Shares of BIO-key Intl were trading at $1.05 as of November 12. Over the last 52-week period, shares are down 64.59%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
To track all earnings releases for BIO-key Intl visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
